PubRank

Pieter H Reitsma

Author PubWeight™ 78.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene variants associated with deep vein thrombosis. JAMA 2008 2.74
2 Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005 2.46
3 Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med 2006 1.82
4 New fundamentals in hemostasis. Physiol Rev 2013 1.70
5 Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 2012 1.70
6 Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2002 1.62
7 The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 2011 1.61
8 Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Crit Care Med 2006 1.60
9 Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med 2005 1.58
10 Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med 2007 1.54
11 Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study. Am J Med 2004 1.50
12 Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology 2003 1.43
13 Factor V Leiden, prothrombin G20210A, and risk of sudden coronary death in apparently healthy persons. Am J Cardiol 2002 1.41
14 IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004 1.35
15 Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 2003 1.22
16 Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002 1.22
17 Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. Blood 2013 1.18
18 Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 2008 1.13
19 Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med 2010 1.11
20 A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. Am J Respir Crit Care Med 2007 1.09
21 Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis 2008 1.06
22 Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2003 1.06
23 Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology 2004 1.06
24 Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood 2007 1.05
25 Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J Clin Immunol 2003 1.05
26 Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med 2008 1.03
27 Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med 2006 1.01
28 Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proc Natl Acad Sci U S A 2013 1.00
29 Blood cell-derived tissue factor influences host response during murine endotoxemia. Blood Cells Mol Dis 2004 0.99
30 Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thromb Haemost 2009 0.98
31 PTX3 predicts severe disease in febrile patients at the emergency department. J Infect 2009 0.96
32 Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis 2004 0.96
33 High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood 2004 0.94
34 Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα. PLoS One 2012 0.90
35 Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease. J Biol Chem 2011 0.89
36 Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes. Thromb J 2005 0.88
37 Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution. Thromb Haemost 2006 0.87
38 Complete abolishment of coagulant activity in monomeric disulfide-deficient tissue factor. Blood 2011 0.87
39 Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis 2008 0.86
40 VKORC1 and the vitamin K cycle. Vitam Horm 2008 0.86
41 Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis. Basic Res Cardiol 2003 0.85
42 High factor VIIa levels do not promote tumor metastasis. Thromb Haemost 2008 0.85
43 Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans. J Infect Dis 2002 0.85
44 High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? Haematologica 2010 0.84
45 Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study. Blood 2013 0.84
46 Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency. Hum Genet 2009 0.83
47 Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production. Blood 2013 0.83
48 Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide. Haematologica 2012 0.83
49 Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited. Thromb Haemost 2006 0.82
50 Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis 2008 0.82
51 Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia. Thromb Haemost 2009 0.82
52 PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations. Hum Mutat 2008 0.82
53 Blood coagulation factors as inflammatory mediators. Blood Cells Mol Dis 2004 0.82
54 Modified two-step model for studying the inflammatory response during myocardial ischemia and reperfusion in mice. Comp Med 2003 0.81
55 The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers. Clin Chem Lab Med 2007 0.81
56 Fentanyl-fluanisone-midazolam combination results in more stable hemodynamics than does urethane alpha-chloralose and 2,2,2-tribromoethanol in mice. Contemp Top Lab Anim Sci 2002 0.81
57 Transgenic mouse models of venous thrombosis: fulfilling the expectations? Semin Thromb Hemost 2007 0.81
58 F9 Malmö, factor IX and deep vein thrombosis. Haematologica 2009 0.81
59 Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events. Am Heart J 2004 0.80
60 Genomics and proteomics: implications for inflammatory bowel diseases. Inflamm Bowel Dis 2004 0.79
61 Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation. Exp Cell Res 2007 0.79
62 Plasma cytokine and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular weight heparin administration. Cancer 2005 0.79
63 Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation. Haematologica 2011 0.78
64 Thrombospondin gene polymorphisms and the risk of angiographic coronary in-stent restenosis. Am J Med 2004 0.78
65 Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model. PLoS One 2013 0.78
66 Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis. Thromb Haemost 2011 0.78
67 Updated analysis of gene variants associated with deep vein thrombosis. JAMA 2010 0.78
68 Regulation of the F11, Klkb1, Cyp4v3 gene cluster in livers of metabolically challenged mice. PLoS One 2013 0.77
69 Quantitative trait locus for protein C in a family with thrombophilia. Thromb Haemost 2010 0.77
70 Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes. Diabetes Care 2004 0.77
71 Tissue factor associates with survival and regulates tumour progression in osteosarcoma. Thromb Haemost 2016 0.76
72 Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation. Thromb Res 2009 0.76
73 Expression of inflammation-related genes in endothelial cells is not directly affected by microparticles from preeclamptic patients. J Lab Clin Med 2006 0.76
74 Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice. Blood Coagul Fibrinolysis 2007 0.76
75 Relationship between in vitro lipopolysaccharide-induced cytokine response in whole blood, angiographic in-stent restenosis, and toll-like receptor 4 gene polymorphisms. Clin Chem 2005 0.76
76 Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects. Am J Epidemiol 2016 0.76
77 Renal tissue factor expression is increased in streptozotocin-induced diabetic mice. Nephron Exp Nephrol 2005 0.75
78 Factor IX-R338L (Factor IX Padua) screening in a Dutch population of sibpairs with early onset venous thromboembolism. Thromb Res 2011 0.75
79 Factor XI gene analysis in thrombophilia and factor XI deficiency. J Thromb Haemost 2004 0.75
80 Progestins possess poor anti-estrogenic activity on murine hepatic coagulation gene transcription despite evident anti-estrogenic activity on uterine tissue. Thromb Res 2011 0.75
81 Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation. Clin Chem Lab Med 2005 0.75
82 Fibrinogen Aalpha312 and Bbeta448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment. Thromb Haemost 2007 0.75
83 Storage and secretion of naturally occurring von Willebrand factor A domain variants. Br J Haematol 2014 0.75
84 Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis. Atherosclerosis 2002 0.75
85 Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity. Thromb Res 2008 0.75